We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection (TURPS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01118260
First Posted: May 6, 2010
Last Update Posted: May 6, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Asker & Baerum Hospital
April 7, 2010
May 6, 2010
May 6, 2010
January 2006
May 2009   (Final data collection date for primary outcome measure)
patient satisfaction [ Time Frame: 4 hours ]
Patient satisfaction was measured asking the patient about satisfaction with anaesthesia using a 5-point Linkert scale: totally satisfied - satisfied - neither satisfied nor dissatisfied - dissatisfied - totally dissatisfied Time frame: Start anaesthesia to end post anaesthestic care unit
Same as current
No Changes Posted
time in PACU [ Time Frame: 4 hours ]
period in post anaesthetic care unit
Same as current
Not Provided
Not Provided
 
Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection
TIVA Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection
Comparison of total intravenous anaesthesia with spinal anaesthesia in patients undergoing transurethral prostate resection
Comparison of total intravenous anaesthesia with spinal anaesthesia in patients undergoing transurethral prostate resection regarding patient satisfaction and discharge time
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Prostate
  • Hyperplasia
  • Procedure: total intravenous anaesthesia
    propofol and remifentanil
  • Procedure: spinal anaesthesia
    bupivacaine and fentanyl
  • Active Comparator: TIVA
    Total intravenous anaesthesia (TIVA) with propofol and remifentanil
    Intervention: Procedure: total intravenous anaesthesia
  • Active Comparator: Spinal
    Spinal anaesthesia with bupivacaine and fentanyl
    Intervention: Procedure: spinal anaesthesia
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
101
May 2009
May 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years and older
  • signed informed consent
  • elective transurethral prostata resection

Exclusion Criteria:

  • ASA more than 3
  • kidney disease, liver disease
  • intolerance against bupivacaine, fentanyl, propofol og remifentanil
  • chronic pulmonary disease
  • dementia
Sexes Eligible for Study: Male
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT01118260
2004-002672-42
No
Not Provided
Not Provided
Dr. med. Vegard Dahl, Asker & Baerum Hospital, Vestre Viken HF
Asker & Baerum Hospital
Not Provided
Study Chair: Vegard Dahl, MD, PhD Asker & Baerum Hospital
Principal Investigator: Elisabet Andersson Asker & Baerum Hospital
Asker & Baerum Hospital
May 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP